should anthracyclines be given in advanced gastroesophageal cancer?
Published 7 years ago • 220 plays • Length 5:57Download video MP4
Download video MP3
Similar videos
-
5:52
anthracyclines for her2-positive early breast cancer
-
9:40
multidisciplinary management of locally advanced gastroesophageal cancer
-
0:42
can anthracyclines be omitted in tnbc?
-
3:20
dr. hurvitz on eliminating anthracyclines in her2 breast cancer treatment
-
1:17
dr. durand on anthracyclines in treatments for her2 breast cancer
-
16:58
assessing immune biomarkers of response to anthracyclines in breast cancer
-
5:47
anthracycline-based regimens: perioperative setting for tnbc
-
7:01
antiangiogenesis in gastric/gej cancers: a global view
-
5:22
adding anthracyclines for her2 disease
-
30:40
prediction of response to anthracycline-based chemotherapy in early breast cancer
-
3:10
ebcc 7: ways to predict efficacy of anthracyclines
-
1:24
dr. iyer on erdafitinib-related hyperphosphatemia in metastatic urothelial cancer
-
5:30
the evolving treatment landscape in gastric/gej cancers
-
1:50
anthracycline cardiotoxicity: clinical types
-
5:40
up-front treatment of metastatic gastroesophageal cancer
-
5:16
biology and location of gastroesophageal cancers
-
12:03
anthracycline chemotherapy side effects: cardiotoxicity in breast cancer explained
-
5:34
high-dose anthracycline therapy in aml
-
4:57
selpercatinib benefit for advanced, kinase inhibitor-naïve, ret-mutant medullary thyroid cancer